Intervention
inulin
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownImpact of Supplemental Fiber on Gut and Vascular Health Related in Obesity PhenotypesNCT07095426 · 2025-05-20
RECRUITINGWhole Food Fibers for Support of Key Gut Bacteria for Human HealthNCT07840170 · 2026-11-01
NOT_YET_RECRUITINGEffects of Soluble Fiber Supplements on Sperm Quality in Males With Obesity: a Randomized TrialNCT07112248 · 2025-08-10
COMPLETEDInulin Supplementation in Patients With Type 1 DiabetesNCT05795972 · 2020-06-01
UNKNOWNEffects of Inulin and Arabinoxylan on Satiety, Energy/Food Intake and Changes in the Human Gut MicrobiotaNCT02846454 · 2016-08-01
UNKNOWNEffects of Inulin on Satiety and Food IntakeNCT01025375 · 2009-01-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED2
UNKNOWN2
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
NA6
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.